IP Library › Assignment 054295/0946
Patent Assignment
Reel/Frame 054295/0946

Release of Security Interest

Recorded: 2020-11-03 Pages: 5
Assignor
Assignee
BELLICUM PHARMACEUTICALS, INC.
2130 WEST HOLCOMBE BOULEVARD, SUITE 800, HOUSTON, TEXAS, 77030
Covered Properties (15)
Modified Caspase Polypeptides and Uses Thereof
Patent: 9,434,935 →
Application: 13/792,135 →
Publication: US 2014/0255360
Methods for Controlling T Cell Proliferation
Patent: 9,944,690 →
Application: 14/210,034 →
Publication: US 2014/0286987
Methods for Inducing Partial Apoptosis Using Caspase Polypeptides
Patent: 9,913,882 →
Application: 14/296,404 →
Publication: US 2016/0151465
MODIFIED T CELL COMPRISING A POLYNUCLEOTIDE ENCODING AN INDUCIBLE STIMULATING MOLECULE COMPRISING MyD88, CD40 AND FKBP12
Application: 14/622,018 →
Publication: US 2016/0046700
Costimulation of Chimeric Antigen Receptors by MYD88 and CD40 Polypeptides
Application: 14/842,710 →
Publication: US 2016/0058857
Methods for Controlled Elimination of Therapeutic Cells
Application: 14/968,737 →
Publication: US 2016/0166613
Methods for Controlled Activation or Elimination of Therapeutic Cells
Application: 14/968,853 →
Publication: US 2016/0175359
Modified Caspase Polypeptides and Uses Thereof
Patent: 9,932,572 →
Application: 15/224,441 →
Publication: US 2017/0015987
Dual Controls for Therapeutic Cell Activation or Elimination
Application: 15/377,776 →
Publication: US 2017/0166877
Methods for Inducing Partial Apoptosis Using Caspase Polypeptides
Application: 15/888,948 →
Publication: US 2018/0243384
Modified Caspase Polypeptides and Uses Thereof
Application: 15/901,556 →
Publication: US 2018/0251746
Methods for Controlling T Cell Proliferation
Application: 15/910,380 →
Publication: US 2018/0265566
Methods to Augment or Alter Signal Transduction
Application: 16/611,772 →
Publication: US 2021/0147507
Methods for Inducing Partial Apoptosis Using Caspase Polypeptides
Application: 16/734,104 →
Publication: US 2020/0230216
Costimulation of Chimeric Antigen Receptors by MYD88 and CD40 Polypeptides
Application: 16/788,062 →
Publication: US 2020/0237886
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 18, 2013
From: SPENCER, DAVID; CHANG, WEI-CHUN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 031624/0291 →
Assignment of Assignor's Interest Aug 4, 2014
From: SLAWIN, KEVIN; SPENCER, DAVID; FOSTER, AARON EDWARD
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 033454/0247 →
Assignment of Assignor's Interest Aug 12, 2014
From: SPENCER, DAVID; FOSTER, AARON EDWARD
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 033519/0247 →
Assignment of Assignor's Interest Feb 25, 2015
From: SLAWIN, KEVIN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 035026/0972 →
Assignment of Assignor's Interest Oct 22, 2015
From: SPENCER, DAVID; FOSTER, AARON EDWARD; SLAWIN, KEVIN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 036857/0666 →
Assignment of Assignor's Interest Jan 15, 2016
From: FOSTER, AARON EDWARD; SPENCER, DAVID; COLLINSON-PAUTZ, MATTHEW ROBERT; SLAWIN, KEVIN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 037503/0720 →
Assignment of Assignor's Interest Feb 18, 2016
From: SPENCER, DAVID M.; FOSTER, AARON EDWARD; BAYLE, JOSEPH HENRI; SLAWIN, KEVIN M.
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 037766/0669 →
Assignment of Assignor's Interest Mar 29, 2016
From: SPENCER, DAVID M.; BAYLE, JOSEPH HENRI; FOSTER, AARON EDWARD; SLAWIN, KEVIN M.
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 038128/0830 →
Assignment of Assignor's Interest Oct 6, 2016
From: SPENCER, DAVID; CHANG, WEI-CHUN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 039961/0691 →
Assignment of Assignor's Interest Dec 22, 2016
From: BAYLE, JOSEPH HENRI; DUONG, MYLINH THI; COLLINSON-PAUTZ, MATTHEW ROBERT; FOSTER, AARON EDWARD
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 040752/0892 →
Assignment of Assignor's Interest Mar 7, 2018
From: SLAWIN, KEVIN; SPENCER, DAVID; FOSTER, AARON EDWARD
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 045134/0477 →
Assignment of Assignor's Interest Mar 7, 2018
From: SPENCER, DAVID; CHANG, WEI-CHUN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 045134/0526 →
Assignment of Assignor's Interest Mar 7, 2018
From: SPENCER, DAVID; FOSTER, AARON EDWARD; SLAWIN, KEVIN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 045133/0839 →
Security Interest Apr 1, 2020
From: BELLICUM PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 052284/0113 →
Assignment of Assignor's Interest Aug 3, 2020
From: SPENCER, DAVID; FOSTER, AARON EDWARD; SLAWIN, KEVIN
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 053387/0305 →
Assignment of Assignor's Interest Aug 4, 2020
From: BAYLE, JOSEPH HENRI; CHANG, WEI-CHUN; FOSTER, AARON EDWARD; SPENCER, DAVID MICHAEL
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 053400/0020 →
Assignment of Assignor's Interest Aug 18, 2020
From: SLAWIN, KEVIN; SPENCER, DAVID; FOSTER, AARON EDWARD
To: BELLICUM PHARMACEUTICALS, INC.
Reel/Frame 053531/0294 →
Assignment of Assignor's Interest Feb 21, 2024
From: BELLICUM PHARMACEUTICALS, INC.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 066643/0549 →